AG˹ٷ

STOCK TITAN

[Form 4] Lifevantage Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Lifevantage Corp (LFVN) reported a Form 4 showing equity awards to Julie Boyster, the company's Chief Marketing Officer. The filing discloses a non‑derivative grant of 13,102 common stock units on 08/26/2025, increasing her directly held common shares to 128,316. The filing also shows 19,654 Performance Restricted Stock Units (PRSUs) granted the same date, representing rights to receive that many shares if performance targets are met; the PRSUs count as 19,654 underlying shares for beneficial ownership. The stock units vest over time subject to continued service: 5/12 of the stock unit award vests on September 10, 2026, with the remainder in equal installments across seven calendar quarters thereafter. The PRSUs vest only to the extent financial performance criteria are achieved and, if earned, vest in three tranches on September 10, 2026, 2027 and 2028 (34%, 33%, 33%). The Form 4 was signed by a power of attorney on 08/28/2025.

Lifevantage Corp (LFVN) ha comunicato con un Form 4 l'assegnazione di azioni a Julie Boyster, Chief Marketing Officer. La documentazione riporta una concessione non derivata di 13.102 unità di azioni ordinarie il 26/08/2025, portando le sue azioni ordinarie detenute direttamente a 128.316. Il file indica inoltre 19.654 Performance Restricted Stock Units (PRSUs) concesse nella stessa data, che danno diritto a ricevere quel numero di azioni al raggiungimento degli obiettivi di performance; ai fini della proprietà beneficiaria le PRSU sono considerate come 19.654 azioni sottostanti. Le unità azionarie si consolidano progressivamente subordinatamente al mantenimento del rapporto di servizio: 5/12 dell'assegnazione si consolida il 10 settembre 2026, con il resto distribuito in rate uguali su sette trimestri civili successivi. Le PRSU maturano solo al verificarsi dei criteri finanziari prestabiliti e, se conseguite, vengono liquidate in tre tranche il 10 settembre 2026, 2027 e 2028 (34%, 33%, 33%). Il Form 4 è stato firmato con procura il 28/08/2025.

Lifevantage Corp (LFVN) presentó un Form 4 que muestra concesiones de capital a Julie Boyster, la directora de marketing. El documento revela una adjudicación no derivada de 13.102 unidades de acciones ordinarias el 26/08/2025, aumentando sus acciones ordinarias en propiedad directa a 128.316. También figura la concesión de 19.654 Unidades de Acciones Restringidas por Desempeño (PRSUs) en la misma fecha, que otorgan el derecho a recibir ese número de acciones si se cumplen los objetivos; las PRSUs cuentan como 19.654 acciones subyacentes para la titularidad beneficiaria. Las unidades de acciones se consolidan con el tiempo y están supeditadas a la continuidad en el puesto: 5/12 del otorgamiento de unidades se consolida el 10 de septiembre de 2026, y el resto en cuotas iguales a lo largo de siete trimestres civiles posteriores. Las PRSUs solo se hacen efectivas en la medida en que se cumplan los criterios financieros y, de ser ganadas, se liberan en tres tramos el 10 de septiembre de 2026, 2027 y 2028 (34 %, 33 %, 33 %). El Form 4 fue firmado por poder el 28/08/2025.

Lifevantage Corp(LFVN)� 최고마케팅책임자 Julie Boyster� 대� 지� 보상 내역� Form 4� 보고했습니다. 제출서류� 따르� 2025-08-26� 파생상품� 아닌 13,102 보통� 단위가 부여되� 그녀� 직접 보유 보통주가 128,316� 증가했습니다. 같은 날짜� 19,654개의 성과연동제한�(PRSUs)� 부여되었으�, 이는 성과 목표 달성 � 해당 수만큼의 주식� 받을 권리� 의미합니�; PRSUs� 수혜� 소유� 계산� 19,654개의 기초주식으로 간주됩니�. 주식 단위� 계속 근무� 전제� 단계적으� 확정되며, � 부여액� 5/12� 2026� 9� 10일에 확정되고 나머지� 이후 7� 분기� 걸쳐 동일� 비율� 분할 확정됩니�. PRSUs� 재무 성과 기준� 충족� 경우에만 확정되며, 달성� 경우 2026�, 2027�, 2028� 9� 10일에 각각 34%, 33%, 33% 비율� 3회에 걸쳐 확정됩니�. Form 4� 2025-08-28� 위임� 대� 서명으로 제출되었습니�.

Lifevantage Corp (LFVN) a déclaré dans un Form 4 l'attribution d'actions à Julie Boyster, directrice marketing. Le document révèle une attribution non dérivative de 13 102 unités d'actions ordinaires le 26/08/2025, portant ses actions ordinaires détenues directement à 128 316. Le dossier indique également la concession de 19 654 Unités d'Actions Restreintes à Performance (PRSUs) à la même date, donnant droit à recevoir ce nombre d'actions si les objectifs de performance sont atteints ; les PRSUs sont comptées comme 19 654 actions sous‑jacentes pour la détention bénéficiaire. Les unités d'actions acquièrent des droits progressivement sous réserve de la poursuite du service : 5/12 de l'attribution acquiert le 10 septembre 2026, le reste étant réparti en parts égales sur sept trimestres civils suivants. Les PRSUs ne sont acquises que si les critères financiers sont remplis et, si elles sont obtenues, elles se libèrent en trois tranches les 10 septembre 2026, 2027 et 2028 (34 %, 33 %, 33 %). Le Form 4 a été signé par procuration le 28/08/2025.

Lifevantage Corp (LFVN) meldete in einem Form 4 Aktienzuteilungen an Julie Boyster, die Chief Marketing Officer des Unternehmens. Die Einreichung weist eine nicht‑derivative Zuteilung von 13.102 Stammaktieneinheiten zum 26.08.2025 aus, wodurch ihre unmittelbar gehaltenen Stammaktien auf 128.316 steigen. Ebenfalls aufgeführt sind 19.654 Performance Restricted Stock Units (PRSUs), die am selben Datum gewährt wurden und Anspruch auf diese Anzahl von Aktien bei Erreichen der Leistungsziele gewähren; für die vorteilhafte Eigentümerschaft zählen die PRSUs als 19.654 zugrunde liegende Aktien. Die Aktieneinheiten vesten zeitlich gestaffelt unter der Bedingung fortgesetzter Dienstzeit: 5/12 der Zuteilung vesten am 10. September 2026, der Rest in gleichen Raten über sieben anschließende Kalenderquartale. Die PRSUs vesten nur, wenn finanzielle Leistungskennzahlen erfüllt werden, und werden, falls verdient, in drei Tranchen am 10. September 2026, 2027 und 2028 freigegeben (34%, 33%, 33%). Das Form 4 wurde am 28.08.2025 mittels Vollmacht unterzeichnet.

Positive
  • 13,102 common stock units were granted to the Chief Marketing Officer on 08/26/2025
  • 19,654 Performance Restricted Stock Units (PRSUs) were granted on 08/26/2025
  • Vesting schedules are specified, tying awards to continued service and to achievement of performance criteria
Negative
  • None.

Insights

TL;DR: Executive awarded time‑based stock units and performance shares to align incentives with future service and performance.

The filing documents a routine executive compensation event: a time‑based grant of 13,102 common stock units and 19,654 PRSUs for the Chief Marketing Officer. Vesting schedules combine service‑based installments and performance‑contingent vesting, with clear tranche dates spanning 2026�2028. From a governance perspective, this structure ties pay to multi‑period performance and retention without disclosing absolute performance targets or potential expense impact. The disclosure is specific on quantities and vesting timing but does not include performance metric details or grant valuation.

TL;DR: Insider reported acquisitions of stock units and PRSUs increasing beneficial ownership; transaction appears as compensation, not open‑market trading.

The Form 4 shows acquisitions coded as 'A' with $0 price, indicating awards rather than market purchases. Beneficial ownership after the grants is stated as 128,316 common shares and 19,654 shares underlying PRSUs. The filing follows Section 16 reporting requirements and was executed via power of attorney. No information in the filing indicates transfers, sales, or hedging arrangements. Material financial effects (expense recognition, dilution) are not disclosed here and would appear in periodic filings.

Lifevantage Corp (LFVN) ha comunicato con un Form 4 l'assegnazione di azioni a Julie Boyster, Chief Marketing Officer. La documentazione riporta una concessione non derivata di 13.102 unità di azioni ordinarie il 26/08/2025, portando le sue azioni ordinarie detenute direttamente a 128.316. Il file indica inoltre 19.654 Performance Restricted Stock Units (PRSUs) concesse nella stessa data, che danno diritto a ricevere quel numero di azioni al raggiungimento degli obiettivi di performance; ai fini della proprietà beneficiaria le PRSU sono considerate come 19.654 azioni sottostanti. Le unità azionarie si consolidano progressivamente subordinatamente al mantenimento del rapporto di servizio: 5/12 dell'assegnazione si consolida il 10 settembre 2026, con il resto distribuito in rate uguali su sette trimestri civili successivi. Le PRSU maturano solo al verificarsi dei criteri finanziari prestabiliti e, se conseguite, vengono liquidate in tre tranche il 10 settembre 2026, 2027 e 2028 (34%, 33%, 33%). Il Form 4 è stato firmato con procura il 28/08/2025.

Lifevantage Corp (LFVN) presentó un Form 4 que muestra concesiones de capital a Julie Boyster, la directora de marketing. El documento revela una adjudicación no derivada de 13.102 unidades de acciones ordinarias el 26/08/2025, aumentando sus acciones ordinarias en propiedad directa a 128.316. También figura la concesión de 19.654 Unidades de Acciones Restringidas por Desempeño (PRSUs) en la misma fecha, que otorgan el derecho a recibir ese número de acciones si se cumplen los objetivos; las PRSUs cuentan como 19.654 acciones subyacentes para la titularidad beneficiaria. Las unidades de acciones se consolidan con el tiempo y están supeditadas a la continuidad en el puesto: 5/12 del otorgamiento de unidades se consolida el 10 de septiembre de 2026, y el resto en cuotas iguales a lo largo de siete trimestres civiles posteriores. Las PRSUs solo se hacen efectivas en la medida en que se cumplan los criterios financieros y, de ser ganadas, se liberan en tres tramos el 10 de septiembre de 2026, 2027 y 2028 (34 %, 33 %, 33 %). El Form 4 fue firmado por poder el 28/08/2025.

Lifevantage Corp(LFVN)� 최고마케팅책임자 Julie Boyster� 대� 지� 보상 내역� Form 4� 보고했습니다. 제출서류� 따르� 2025-08-26� 파생상품� 아닌 13,102 보통� 단위가 부여되� 그녀� 직접 보유 보통주가 128,316� 증가했습니다. 같은 날짜� 19,654개의 성과연동제한�(PRSUs)� 부여되었으�, 이는 성과 목표 달성 � 해당 수만큼의 주식� 받을 권리� 의미합니�; PRSUs� 수혜� 소유� 계산� 19,654개의 기초주식으로 간주됩니�. 주식 단위� 계속 근무� 전제� 단계적으� 확정되며, � 부여액� 5/12� 2026� 9� 10일에 확정되고 나머지� 이후 7� 분기� 걸쳐 동일� 비율� 분할 확정됩니�. PRSUs� 재무 성과 기준� 충족� 경우에만 확정되며, 달성� 경우 2026�, 2027�, 2028� 9� 10일에 각각 34%, 33%, 33% 비율� 3회에 걸쳐 확정됩니�. Form 4� 2025-08-28� 위임� 대� 서명으로 제출되었습니�.

Lifevantage Corp (LFVN) a déclaré dans un Form 4 l'attribution d'actions à Julie Boyster, directrice marketing. Le document révèle une attribution non dérivative de 13 102 unités d'actions ordinaires le 26/08/2025, portant ses actions ordinaires détenues directement à 128 316. Le dossier indique également la concession de 19 654 Unités d'Actions Restreintes à Performance (PRSUs) à la même date, donnant droit à recevoir ce nombre d'actions si les objectifs de performance sont atteints ; les PRSUs sont comptées comme 19 654 actions sous‑jacentes pour la détention bénéficiaire. Les unités d'actions acquièrent des droits progressivement sous réserve de la poursuite du service : 5/12 de l'attribution acquiert le 10 septembre 2026, le reste étant réparti en parts égales sur sept trimestres civils suivants. Les PRSUs ne sont acquises que si les critères financiers sont remplis et, si elles sont obtenues, elles se libèrent en trois tranches les 10 septembre 2026, 2027 et 2028 (34 %, 33 %, 33 %). Le Form 4 a été signé par procuration le 28/08/2025.

Lifevantage Corp (LFVN) meldete in einem Form 4 Aktienzuteilungen an Julie Boyster, die Chief Marketing Officer des Unternehmens. Die Einreichung weist eine nicht‑derivative Zuteilung von 13.102 Stammaktieneinheiten zum 26.08.2025 aus, wodurch ihre unmittelbar gehaltenen Stammaktien auf 128.316 steigen. Ebenfalls aufgeführt sind 19.654 Performance Restricted Stock Units (PRSUs), die am selben Datum gewährt wurden und Anspruch auf diese Anzahl von Aktien bei Erreichen der Leistungsziele gewähren; für die vorteilhafte Eigentümerschaft zählen die PRSUs als 19.654 zugrunde liegende Aktien. Die Aktieneinheiten vesten zeitlich gestaffelt unter der Bedingung fortgesetzter Dienstzeit: 5/12 der Zuteilung vesten am 10. September 2026, der Rest in gleichen Raten über sieben anschließende Kalenderquartale. Die PRSUs vesten nur, wenn finanzielle Leistungskennzahlen erfüllt werden, und werden, falls verdient, in drei Tranchen am 10. September 2026, 2027 und 2028 freigegeben (34%, 33%, 33%). Das Form 4 wurde am 28.08.2025 mittels Vollmacht unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Boyster Julie

(Last) (First) (Middle)
3300 TRIUMPH BLVD, SUITE 700

(Street)
LEHI UT 84043

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Marketing Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 08/26/2025 A 13,102 A $0 128,316 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Stock Units(2) (3) 08/26/2025 A V 19,654 (3) (3) Common Stock 19,654 $0 19,654 D
Explanation of Responses:
1. This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter.
2. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units.
3. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.
Remarks:
/s/ Alissa Neufeld, Power of Attorney for Julie Boyster 08/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Julie Boyster receive according to the Form 4 for LFVN?

The Form 4 shows a grant of 13,102 common stock units and 19,654 Performance Restricted Stock Units on 08/26/2025.

How many common shares will Julie Boyster beneficially own after the reported transaction?

Following the reported transaction, she beneficially owns 128,316 shares of common stock and has 19,654 shares underlying PRSUs.

When do the awarded stock units and PRSUs vest?

The stock units vest with 5/12 on September 10, 2026 and the remainder in equal installments across seven calendar quarters thereafter; earned PRSUs vest 34% on September 10, 2026, 33% on September 10, 2027, and 33% on September 10, 2028.

Are the PRSUs guaranteed shares?

No. The PRSUs vest only to the extent specified financial performance criteria are achieved and subject to continued service.

Was the Form 4 signed by the reporting person?

The filing was signed on behalf of Julie Boyster by Alissa Neufeld, Power of Attorney on 08/28/2025.
Lifevantage Corp

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Latest SEC Filings

LFVN Stock Data

152.44M
10.25M
15.23%
65.86%
18.78%
Packaged Foods
Pharmaceutical Preparations
United States
LEHI